Former CDMA president Jim Devine dies
His commitment to CDMA led him to attend trade shows, develop new endeavors, and consistently voice his support of the association, while appreciating its fragility in a changing marketplace.
Latest
MedOne offers expedited access to Stelara biosimilars
The much-anticipated biosimilars for ustekinumab, commonly known by its brand name Stelara, are set to hit the market in mid-2025.
NACDS promotes Terry Arth to SVP of Member Services and Conferences
“Terry has been a visionary and disciplined leader in making NACDS meetings and conferences the gold standard in the industry,” said NACDS president and CEO Steven Anderson.
Novo Nordisk introduces NovoCare Pharmacy, lowering cost of all doses of approved Wegovy
NovoCare Pharmacy provides direct-to-patient, convenient home shipments of all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients.
Save the date for CRN’s signature dietary supplement and functional food industry events: Oct. 8–10 in St. Louis
CONVERGENCE ‘25, on Oct. 9 – 10, brings industry professionals together for the main business conference, known for its thought-provoking and forward-looking topics, inspiring speakers, and the industry-defining discussions that take place.
Report: A decade of biosimilars and barriers remain
Matrix Global Advisors report highlights current barriers and recommendations for robust competition and patient savings in the next decade.
Report from CoverMyMeds looks at actionable strategies to bridge gaps for patients
CoverMyMeds' 2025 Medication Access Report: From Barriers to Bridges calls for increased collaboration and interoperability across the healthcare industry to improve patient outcomes.
NIQ Brandbank and RangeMe team to enhance product discovery for wellness categories
Through this collaboration, NIQ Brandbank’s verified product data will integrate seamlessly with RangeMe’s platform.
RILA urges Trump to prioritize renewing TCJA
"Tariffs on Canada and Mexico in particular risk destabilizing the North American economy," says RILA's Michael Hanson.
Target reveals $15 billion growth plan for 2030
Target aims to elevate its product assortment with innovations and strategic partnerships as part of the plan.
CRN unveils 2025 ‘Day on the Hill’ to promote supplement sector
As lawmakers prioritize health, CRN’s 2025 Day on the Hill will highlight the industry’s crucial role in offering safe, effective, science-backed nutrition products.
Wellvana acquires CVS Health’s MSSP business
With latest transaction, Wellvana supports primary care providers across 40 states, serving approximately 1 million patients.
NRF: Negotiate with Canada and Mexico instead of imposing tariffs
“Tariffs are just one tool at the administration’s disposal to achieve a secure border,” says NRF's David French.
New report from GoodRx tracks changes in GLP-1 insurance coverage
In 2025, the number of people without commercial insurance coverage for these medications surged significantly. Zepbound saw a 14% increase since 2024, leaving 4.9 million people without coverage, and Ozempic saw a 22% increase, affecting another 1.1 million people.
Target reports strong Q4 with cautious 2025 outlook
“Our team grew traffic and delivered better-than-expected sales and profitability in our biggest quarter of the year,” said Target's CEO.
Upcoming NCPA items for pharmacy teams
One webinar will explore practical strategies for managing stress, mastering self-care, and fostering a resilient, well-supported working environment.